Literature DB >> 20380409

Thermodynamic studies and loading of 7-ethyl-10-hydroxycamptothecin into mesoporous silica particles MCM-41 in strongly acidic solutions.

Rishi Thakur1, Balasubramanian Sivakumar, Michalakis Savva.   

Abstract

A major limitation of the clinical efficacy of the 7-ethyl-10-hydroxycamptothecin (SN38) therapy is its facile conversion of the active lactone form into a less active carboxylate species at physiological pH and limited aqueous solubility. The present manuscript embodies a detailed description of several physicochemical properties of SN38 and further details the thermodynamic basis for its poor aqueous solubility. The ionization and increased solubility of the drug in highly acidic media were subsequently employed to efficiently load the positively charged drug in its biologically active lactone form into mesoporous silica material of type MCM-41, achieving a maximum loading of 250 mg of SN38 per gram of silicate. It was also found that the equilibrium association constant K(A) varies with the extent of drug adsorption. At low and high drug load, corresponding to one SN38 molecule bound for every 70 and 13 -SiO(2)-, K(A) was determined to be 1253.5 and 127.39 M(-1), respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380409     DOI: 10.1021/jp100170d

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  5 in total

1.  Physicochemical characterization of 9-aminocamptothecin in aqueous solutions.

Authors:  Shahidur Rahman; Deval Patel; Michalakis Savva
Journal:  AAPS PharmSciTech       Date:  2013-12-03       Impact factor: 3.246

2.  In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.

Authors:  Min Chen; Wanqing Li; Xun Zhang; Ye Dong; Yabing Hua; Hui Zhang; Jing Gao; Liang Zhao; Ying Li; Aiping Zheng
Journal:  Int J Nanomedicine       Date:  2017-08-01

3.  SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.

Authors:  Yi-Ping Fang; Chih-Hung Chuang; Yi-Jhun Wu; Hsin-Che Lin; Yun-Chi Lu
Journal:  Int J Nanomedicine       Date:  2018-05-10

4.  Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy.

Authors:  Ye Bi; Robert J Lee; Xinyu Wang; Yating Sun; Mengqiao Wang; Lianlian Li; Chenliang Li; Jing Xie; Lesheng Teng
Journal:  Int J Nanomedicine       Date:  2018-10-04

5.  Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.

Authors:  Hao Su; Pengcheng Zhang; Andrew G Cheetham; Jin Mo Koo; Ran Lin; Asad Masood; Paula Schiapparelli; Alfredo Quiñones-Hinojosa; Honggang Cui
Journal:  Theranostics       Date:  2016-04-28       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.